Physician profile
Barbara Schroeder
NPI 1750383014
$9,118.32
in general payments reported to CMS, 2019-2025
37 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $233 · 2021: $7,318 · 2022: $229 · 2023: $426 · 2024: $469 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,937.55 | 2021 | |
| Abbvie INC. | $209.95 | 2019-2024 | Liletta, Lo Loestrin Fe |
| Pfizer INC. | $207.10 | 2019-2024 | |
| Gynesonics, INC. | $169.19 | 2023-2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Evofem Biosciences, INC. | $150.28 | 2021-2025 | Phexxi, Solosec, Phexx |
| Hologic Sales and Service, LLC | $126.80 | 2020-2025 | Myosure Tissue Removal Device, Fluent Fluid Management System, Novasure |
| Bayer Healthcare Pharmaceuticals INC. | $122.71 | 2019-2023 | |
| Acelrx Pharmaceuticals, INC. | $120.09 | 2020 | |
| Sumitomo Pharma America, INC. | $112.87 | 2023-2024 | Myfembree |
| Avion Pharmaceuticals | $99.15 | 2020-2022 | |
| Biogen, INC. | $98.25 | 2024-2025 | Zurzuvae |
| Medtronic, INC. | $73.74 | 2023 | V-Loc 180 |
| Merck Sharp & Dohme LLC | $61.21 | 2019-2021 | |
| Therapeuticsmd, INC. | $58.81 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $56.14 | 2022-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $48.58 | 2025 | Perclot |
| Myovant Sciences INC. | $44.57 | 2021-2022 | |
| Boston Scientific Corporation | $37.78 | 2021 | |
| Ascend Therapeutics US, LLC | $35.34 | 2021-2022 | |
| Millicent US INC | $33.66 | 2023-2025 | Femring, Intrarosa |
| Exeltis, USA INC. | $31.07 | 2023-2025 | Slynd |
| Mission Pharmacal Company | $22.70 | 2021 | |
| Organon LLC | $21.98 | 2025 | Nexplanon |
| Ethicon US, LLC | $20.33 | 2025 | Evarrest, Surgiflo Hemostatic Matrix, Ethicon |
| Alafair Biosciences, INC. | $20.11 | 2024 | Versawrap |
| Abbott Laboratories | $19.61 | 2024 | Proclaim |
| Lupin INC. | $19.11 | 2021 | |
| Dexcom, INC. | $18.91 | 2025 | Dexcom G6 Transmitter |
| Optumhealth Care Solutions, LLC | $18.60 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Coopersurgical, INC. | $18.36 | 2024 | Paragard T 380a |
| Astellas Pharma US INC | $17.81 | 2021 | |
| Davol INC. | $17.25 | 2022 | |
| Amag Pharmaceuticals, INC. | $14.48 | 2019 | |
| Exact Sciences Corporation | $14.21 | 2023 | Cologuard Collection Kit |
| Covidien LP | $13.80 | 2020 | |
| Allergan, INC. | $13.18 | 2019 | |
| Acessa Health INC. | $13.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barbara Schroeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.